HK49497A - Antibody to human interleukin-6 receptor - Google Patents

Antibody to human interleukin-6 receptor Download PDF

Info

Publication number
HK49497A
HK49497A HK49497A HK49497A HK49497A HK 49497 A HK49497 A HK 49497A HK 49497 A HK49497 A HK 49497A HK 49497 A HK49497 A HK 49497A HK 49497 A HK49497 A HK 49497A
Authority
HK
Hong Kong
Prior art keywords
receptor
antibody
cells
human
human interleukin
Prior art date
Application number
HK49497A
Other languages
German (de)
English (en)
Inventor
Kishimoto Tadamitsu
Original Assignee
Kishimoto Tadamitsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kishimoto Tadamitsu filed Critical Kishimoto Tadamitsu
Publication of HK49497A publication Critical patent/HK49497A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Claims (5)

  1. Procédé de préparation d'un anticorps du récepteur de l'interleukine-6 anti-humaine, qui comprend la mise en culture d'un hybridome qui produit un anticorps monoclonal capable de se lier spécifiquement avec un récepteur de l'interleukine-6 humaine et qui rivalise avec l'interleukine-6 humaine pour se lier avec un récepteur de l'interleukine-6 humaine.
  2. Procédé de préparation d'un peptide présentant la séquence :    KTSMHPPYSLGQLVPC (ID n°1) qui comprend la synthèse du peptide par des méthodes classiques en utilisant les acides aminés appropriés
  3. Procédé selon la revendication 1, caractérisé en ce que l'anticorps du récepteur de l'interleukine-6 anti-humaine est l'anticorps PM1 (FERM BP-2998).
HK49497A 1989-07-20 1997-04-17 Antibody to human interleukin-6 receptor HK49497A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18601689 1989-07-20

Publications (1)

Publication Number Publication Date
HK49497A true HK49497A (en) 1997-04-25

Family

ID=16180912

Family Applications (1)

Application Number Title Priority Date Filing Date
HK49497A HK49497A (en) 1989-07-20 1997-04-17 Antibody to human interleukin-6 receptor

Country Status (10)

Country Link
EP (1) EP0409607B1 (fr)
JP (1) JP2998976B2 (fr)
KR (1) KR100214759B1 (fr)
AT (1) ATE144713T1 (fr)
CA (1) CA2021594C (fr)
DE (2) DE122009000023I2 (fr)
ES (1) ES2093017T3 (fr)
HK (1) HK49497A (fr)
NL (1) NL300387I1 (fr)
SG (1) SG42954A1 (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05236966A (ja) * 1991-04-25 1993-09-17 Chugai Pharmaceut Co Ltd ヒトインターロイキン−６レセプターに対するマウスモノクローナル抗体の可変領域をコードするｄｎａ
US5795965A (en) 1991-04-25 1998-08-18 Chugai Seiyaku Kabushiki Kaisha Reshaped human to human interleukin-6 receptor
FR2694767B1 (fr) * 1992-08-13 1994-10-21 Innotherapie Lab Sa Anticorps monoclonaux anti-IL6R, et leurs applications.
AU7967294A (en) * 1993-10-06 1995-05-01 Board Of Regents, The University Of Texas System A monoclonal anti-human il-6 receptor antibody
US8017121B2 (en) 1994-06-30 2011-09-13 Chugai Seiyaku Kabushika Kaisha Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
US5856098A (en) * 1994-09-14 1999-01-05 Progenitor, Inc. Detection of a leptin receptor variant
US5912123A (en) * 1994-09-14 1999-06-15 Progenitor, Inc. Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
US6451523B1 (en) 1994-09-14 2002-09-17 Interneuron Pharmaceuticals, Inc. Detection of a leptin receptor variant and methods for regulating obesity
US5763211A (en) * 1994-09-14 1998-06-09 Progenitor, Inc. Isolated nucleic acid encoding Hu-B1.219, a novel human hematopoietin
US6355237B1 (en) 1994-09-14 2002-03-12 Progenitor, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development
US5643748A (en) 1994-09-14 1997-07-01 Progenitor, Inc. HU-B1.219, a novel human hematopoietin receptor
ES2384222T3 (es) * 1994-10-07 2012-07-02 Chugai Seiyaku Kabushiki Kaisha Inhibición del crecimiento anómalo de células sinoviales utilizando un antagonista de IL-6 como principio activo
CN1306963C (zh) * 1994-10-21 2007-03-28 岸本忠三 用于治疗il－6产生所致疾病的药物组合物
JP3458512B2 (ja) 1995-02-23 2003-10-20 東ソー株式会社 骨密度の変動推定方法又は骨そしょう症の診断方法及びこれに用いる試薬キット
AU1833197A (en) * 1996-01-18 1997-08-11 Progenitor, Inc. Detection of a leptin receptor variant and methods for regulating obesity
US6692742B1 (en) * 1996-06-27 2004-02-17 Chugai Seiyaku Kabushiki Kaisha Remedies for myeloma to be used together with nitrogen mustard antitumor agents
JP5485489B2 (ja) 2000-08-11 2014-05-07 中外製薬株式会社 抗体含有安定化製剤
CN1259973C (zh) * 2000-10-25 2006-06-21 中外制药株式会社 含有il－6拮抗剂作为有效成分的牛皮癣的预防或治疗剂
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
MXPA06003768A (es) 2003-10-17 2006-06-23 Chugai Pharmaceutical Co Ltd Agente terapeutico para el mesotelioma.
AR058135A1 (es) 2005-10-21 2008-01-23 Chugai Pharmaceutical Co Ltd Agentes para el tratamiento de cardiopatias
AR057582A1 (es) 2005-11-15 2007-12-05 Nat Hospital Organization Agentes para suprimir la induccion de linfocitos t citotoxicos
TW200803894A (en) 2005-11-25 2008-01-16 Univ Keio Prostate cancer therapeutic agents
AU2007208678B2 (en) 2006-01-27 2013-01-10 Chugai Seiyaku Kabushiki Kaisha Therapeutic agents for diseases involving choroidal neovascularization
JP5754875B2 (ja) 2006-04-07 2015-07-29 国立大学法人大阪大学 筋再生促進剤
US8080248B2 (en) 2006-06-02 2011-12-20 Regeneron Pharmaceuticals, Inc. Method of treating rheumatoid arthritis with an IL-6R antibody
JP5307708B2 (ja) 2006-06-02 2013-10-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトｉｌ−６受容体に対する高親和性抗体
WO2008020079A1 (fr) 2006-08-18 2008-02-21 Ablynx N.V. Séquences d'acides aminés dirigées contre l'il-6r et polypeptides les contenant utilisés pour le traitement de maladies et de troubles associés au signal médié par il-6
CN101528778A (zh) * 2006-08-18 2009-09-09 埃博灵克斯股份有限公司 用于治疗与il-6-介导的信号传导相关的疾病和病症的针对il-6r的氨基酸序列以及包括其的多肽
WO2008071685A1 (fr) * 2006-12-13 2008-06-19 Ablynx N.V. Polypeptides spécifiques de complexes impliqués dans une voie de signalisation médiée par un récepteur, tel que le complexe il-6/récepteur il-6
EP2174667B1 (fr) 2007-07-26 2017-01-04 Osaka University Agent pour le traitement de l'ophtalmie contenant un inhibiteur du récepteur de l'interleukine 6 en tant qu'ingrédient actif
RU2490025C2 (ru) 2007-10-02 2013-08-20 Чугаи Сейяку Кабусики Кайся Терапевтические средства, используемые против реакции трансплантат против хозяина, содержащие в качестве активного ингредиента ингибитор рецептора интерлейкина-6
MX2010012031A (es) 2008-05-13 2011-01-20 Novimmune Sa Anticuerpos anti-il-6/il-6r y metodos de uso de los mismos.
CA2728243C (fr) 2008-06-05 2020-03-10 Chugai Seiyaku Kabushiki Kaisha Inhibiteur de neuro-invasion
NZ595461A (en) 2009-04-10 2013-01-25 Ablynx Nv Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
WO2010115995A2 (fr) 2009-04-10 2010-10-14 Ablynx Nv Séquences d'acides aminés améliorées dirigées contre l'il-6r et polypeptides les comprenant pour le traitement des maladies et des troubles liés à l'il-6r
WO2011013786A1 (fr) 2009-07-31 2011-02-03 Maeda Shin Inhibiteur de métastases cancéreuses
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
WO2011149051A1 (fr) 2010-05-28 2011-12-01 中外製薬株式会社 Agent améliorant la réponse de lymphocytes t anti-tumoraux
WO2013041722A1 (fr) 2011-09-23 2013-03-28 Ablynx Nv Inhibition prolongée d'une signalisation à médiation par l'interleukine-6
TWI589299B (zh) 2011-10-11 2017-07-01 再生元醫藥公司 用於治療類風濕性關節炎之組成物及其使用方法
US10782290B2 (en) 2013-06-11 2020-09-22 National Center Of Neurology And Psychiatry Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
US9017678B1 (en) 2014-07-15 2015-04-28 Kymab Limited Method of treating rheumatoid arthritis using antibody to IL6R
DE202014010499U1 (de) 2013-12-17 2015-10-20 Kymab Limited Targeting von humaner PCSK9 zur Cholesterinbehandlung
CA2963712A1 (fr) 2014-10-21 2016-04-28 Ablynx Nv Traitement de maladies associees a il-6r
WO2018203545A1 (fr) 2017-05-02 2018-11-08 国立研究開発法人国立精神・神経医療研究センター Procédé de prédiction et d'évaluation d'un effet thérapeutique dans des maladies associées à il-6 et à des neutrophiles
WO2019151418A1 (fr) 2018-01-31 2019-08-08 元一 加藤 Agent thérapeutique pour l'asthme contenant un inhibiteur d'il-6
MA54861A (fr) 2019-01-31 2021-12-08 Regeneron Pharma Anticorps anti-récepteur de l'il6 pour traiter l'arthrite idiopathique juvénile
SG11202111742QA (en) 2019-04-24 2021-11-29 Sanofi Biotechnology Methods of diagnosis and treatment of rheumatoid arthritis
CA3142710A1 (fr) 2019-06-04 2020-12-10 Sanofi Biotechnology Compositions et procedes de traitement de la douleur chez des sujets atteints de polyarthrite rhumatoide
EP4263602A1 (fr) 2020-12-18 2023-10-25 Ablynx N.V. Polypeptides comprenant des domaines variables uniques d'immunoglobuline ciblant il-6 et tnf-alpha
WO2025198912A1 (fr) 2024-03-21 2025-09-25 Hoffmann-La Roche Inc. Méthodes de traitement de la myasthénie grave

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2598666B2 (ja) * 1987-10-19 1997-04-09 忠三 岸本 抗ヒトｂｃｄｆモノクローナル抗体
CA1341152C (fr) * 1988-01-22 2000-12-12 Tadamitsu Kishimoto Proteine du recepteur du facteur d'induction des cellules humaines b2

Also Published As

Publication number Publication date
ATE144713T1 (de) 1996-11-15
NL300387I1 (nl) 2009-07-01
SG42954A1 (en) 1997-10-17
DE69029015T2 (de) 1998-01-22
EP0409607B1 (fr) 1996-10-30
CA2021594A1 (fr) 1991-01-21
DE122009000023I2 (de) 2010-12-16
EP0409607A3 (en) 1991-06-12
CA2021594C (fr) 2002-01-08
DE122009000023I1 (de) 2009-08-06
JP2998976B2 (ja) 2000-01-17
DE69029015D1 (de) 1996-12-05
JPH03139293A (ja) 1991-06-13
ES2093017T3 (es) 1996-12-16
EP0409607A2 (fr) 1991-01-23
KR100214759B1 (ko) 1999-08-02

Similar Documents

Publication Publication Date Title
EP0409607B1 (fr) Anticorps contre le récepteur de l'interleukin-6
US5670373A (en) Antibody to human interleukin-6 receptor
Carrel et al. Subsets of human Ia-like molecules defined by monoclonal antibodies
EP0411946B1 (fr) DNA codant pour la protéine GP130 humaine
Borrebaeck Strategy for the production of human monoclonal antibodies using in vitro activated B cells
US4636463A (en) Antibodies to human interleukin-2 induced by synthetic polypeptides
EP0604693A1 (fr) Anticorps monoclonaux contre le récepteur de l'interleukine-4 humain et hydridomes les produisant
JP2898040B2 (ja) ｇｐ１３０蛋白質に対する抗体
Ida et al. Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis
KR100301189B1 (ko) 당단백질피(p)에대한단일클론항체
EP0162034B1 (fr) Méthode pour isoler des anticorps monoclonaux de cultures d'hybridomes
KR19980066046A (ko) 고역가의 CTLA4-Ig 융합단백질
Tsujisaki et al. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11–351 and KS1
US4845198A (en) Hybridoma antibody which binds IL-2 receptor
EP0265384A2 (fr) Anticorps monoclonaux d'un facteur stimulant les colonies
CA1337050C (fr) Anticorps monoclonal se liant selectivement a un nouveau g-csf
US5106746A (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
EP0436400B1 (fr) Antigène intracellulaire d'une sous-population de T-lymphocytes CD9-positives et un anticorps monoclonal réagissant avec cela
Eisenbarth et al. Application of monoclonal antibody techniques to endocrinology
EP0347728B1 (fr) Anticorps monoclonal contre la lymphotoxine humaine et son utilisation
US5223611A (en) DNA encoding for human GP130 protein
KR100244579B1 (ko) 인간 인터로이킨-6 수용체에 대한 항체, 이를 생산하는 히브리도마 및 이들의 제조방법
EP0265847B1 (fr) Anticorps monoclonal réagissant avec le TRF (interleukine 5)
Zurawski Jr et al. Continuously proliferating human cell lines synthesizing antibody of predetermined specificity
JPH0653067B2 (ja) 新規ハイブリドーマおよびその製造法

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100718